Case Study: Top-20 Pharmaceutical Company achieves 97% training compliance and completes enrollment seven months early with Advarra's Longboat platform

Helping to Ensure the Success of a Phase III Vaccine Trial

Top-20 Pharmaceutical Company ran a large Phase III vaccine trial across 28 sites in eight Latin American and Asia-Pacific countries and needed rapid, standardized training and onboarding for 648 site staff to ensure readiness to enroll 20,000 patients during a narrow seasonal window. They engaged Advarra, using Advarra’s Longboat platform (a 21 CFR Part 11–compliant online training hub) to deliver protocol, safety and GCP training and site-ready resources.

Advarra implemented Longboat with animated, subtitled training videos, a central document repository, and real-time training reporting plus continuous onboarding to manage staff turnover. The program drove 97% training compliance across all sites, with 18% of training occurring during study initiation, and helped the sponsor complete enrollment seven months early while supporting enrollment of 20,000 patients.